PRDM9 and cancer: Overexpression of histone methyltransferases has been observed in multiple cancer types and is known to play a crucial role in cancer progression and metastasis (Kim et al., 2023, Kim et al., 2022, Kim et al., 2020, Lee et al., 2021, Ryu et al., 2022).